NCT00720018View on ClinicalTrials.gov

Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Migraine Disorders
Interventions
DRUG

NP101 Sumatriptan Iontophoretic Transdermal Patch

NP101 transdermal patch delivering sumatriptan for 4 hours.

Trial Locations (1)

55114

Prism Research, Saint Paul

Sponsors

Lead Sponsor

NuPathe Inc.
All Listed Sponsors
lead

NuPathe Inc.

INDUSTRY